Literature DB >> 10863995

Muscle and motor-skill dysfunction in a K+ channel-deficient mouse are not due to altered muscle excitability or fiber type but depend on the genetic background.

J A Sánchez1, C S Ho, D M Vaughan, M C Garcia, R W Grange, R H Joho.   

Abstract

The voltage-gated K+ channel Kv3.1 is expressed in skeletal muscle and in GABAergic interneurons in the central nervous system. Hence, the absence of Kv3.1 K+ channels may lead to a phenotype of myogenic or neurogenic origin, or both. Kv3.1-deficient (Kv3.1-/-) 129/Sv mice display altered contractile properties of their skeletal muscles and show poor performance on a rotating rod. In contrast, Kv3.1-/- mice on the (129/Sv x C57BL/6)F1 background display normal muscle properties and perform like wild-type mice. The correlation of poor performance on the rotating rod with altered muscle properties supports the notion that the skeletal muscle dysfunction in Kv3.1-/- 129/Sv mice may be responsible for the impaired motor skills on the rotating rod. Surprisingly, we did not find major differences between wild-type and Kv3.1-/- 129/Sv skeletal muscles in either the resting or action potential, the delayed-rectifier potassium conductance (gK) or the distribution of fast and slow muscle fibers. These findings suggest that the Kv3.1 K+ channel may not play a major role in the intrinsic excitability of skeletal muscle fibers although its absence leads to slower contraction and relaxation and to smaller forces in muscles of 129/Sv Kv3.1-/- mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863995     DOI: 10.1007/s004240000248

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  9 in total

1.  The mapping of quantitative trait loci underlying strain differences in locomotor activity between 129S6 and C57BL/6J mice.

Authors:  Michele A Kelly; Malcolm J Low; Tamara J Phillips; Edward K Wakeland; Masashi Yanagisawa
Journal:  Mamm Genome       Date:  2003-10       Impact factor: 2.957

2.  Precise localization of the voltage-gated potassium channel subunits Kv3.1b and Kv3.3 revealed in the molecular layer of the rat cerebellar cortex by a pre-embedding immunogold method.

Authors:  Nagore Puente; Juan Mendizabal-Zubiaga; Izaskun Elezgarai; Leire Reguero; Ianire Buceta; Pedro Grandes
Journal:  Histochem Cell Biol       Date:  2010-09-21       Impact factor: 4.304

Review 3.  The role of Kv3-type potassium channels in cerebellar physiology and behavior.

Authors:  Rolf H Joho; Edward C Hurlock
Journal:  Cerebellum       Date:  2009-02-27       Impact factor: 3.847

4.  Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3.

Authors:  F Espinosa; A McMahon; E Chan; S Wang; C S Ho; N Heintz; R H Joho
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

5.  Targeted deletion of Kcne3 impairs skeletal muscle function in mice.

Authors:  Elizabeth C King; Vishal Patel; Marie Anand; Xiaoli Zhao; Shawn M Crump; Zhaoyang Hu; Noah Weisleder; Geoffrey W Abbott
Journal:  FASEB J       Date:  2017-03-29       Impact factor: 5.191

6.  Activation of conventional kinesin motors in clusters by Shaw voltage-gated K+ channels.

Authors:  Joshua Barry; Mingxuan Xu; Yuanzheng Gu; Andrew W Dangel; Peter Jukkola; Chandra Shrestha; Chen Gu
Journal:  J Cell Sci       Date:  2013-03-13       Impact factor: 5.285

7.  Characterisation of electrogenic nutrient absorption in the Cftr TgH(neoim)Hgu mouse model.

Authors:  B Tóth; S Leonhard-Marek; H J Hedrich; G Breves
Journal:  J Comp Physiol B       Date:  2008-03-28       Impact factor: 2.200

8.  Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity.

Authors:  Peter Jukkola; Tomas Guerrero; Victoria Gray; Chen Gu
Journal:  Acta Neuropathol Commun       Date:  2013-10-23       Impact factor: 7.801

9.  Suppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels.

Authors:  Peter Jukkola; Yuanzheng Gu; Amy E Lovett-Racke; Chen Gu
Journal:  Front Mol Neurosci       Date:  2017-10-26       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.